Sarpogrelate HCl, a selective 5-HT2A antagonist, retards the progression of atherosclerosis through a novel mechanism - Concepedia

Concepedia

Publication | Closed Access

Sarpogrelate HCl, a selective 5-HT2A antagonist, retards the progression of atherosclerosis through a novel mechanism

65

Citations

27

References

2003

Year

Toshio Hayashi, Daigo Sumi, Hisako Matsui‐Hirai, Akiko Fukatsu, Juliet Arockia Rani P, Hatsuyo Kano, Taku Tsunekawa, Akihisa Iguchi

Atherosclerosis

InflammationThrombosisMetabolic SyndromeVascular DiseaseNovel MechanismCardiovascular DiseaseMedicineSelective 5-Ht2a AntagonistImmunologyEndothelial DysfunctionVascular BiologyPharmacotherapyPharmacologyAtherosclerosisSarpogrelate Hcl

References

	Year	Citations

Page 1

Page 1